Viewing Study NCT02783157


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-02-13 @ 2:46 AM
Study NCT ID: NCT02783157
Status: TERMINATED
Last Update Posted: 2020-04-06
First Post: 2016-04-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Transcutaneous Autonomic Modulation in Thoracic Surgery
Sponsor: Duke University
Organization:

Study Overview

Official Title: Transcutaneous Autonomic Modulation to Prevent Organ Injury After Thoracic Surgery
Status: TERMINATED
Status Verified Date: 2020-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TON-POINTS
Brief Summary: In this study, the investigators aim to determine whether non-invasive autonomic modulation decreases inflammation and complications after thoracic surgery. The investigators will test the hypothesis that low-level transcutaneous vagal nerve stimulation (LLVNS) during major thoracic surgery reduces inflammation and complications, particularly postoperative atrial fibrillation (POAF). This will be a prospective randomized pilot trial of 200 patients undergoing major thoracic surgery including lobectomy, bilobectomy, or pneumonectomy via either video-assisted thoracoscopic (VAT) or open thoracotomy. Patients will be randomized to receive ether a) LLVNS (n=100) or b) sham LLVNS (n=100) during their procedure. All patients will receive standardized anesthetic, surgical, and post-surgical care. The primary outcome in this study will be time to occurrence of in-hospital POAF, which will be compared between groups using Cox proportional hazards models. Secondary outcomes will be ICU and hospital length of stay, postoperative morbidity, postoperative mortality, and serologic markers of inflammation.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: